Tony Butler
Stock Analyst at Rodman & Renshaw
(1.03)
# 3,472
Out of 4,814 analysts
106
Total ratings
32.35%
Success rate
-13.94%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $6.16 | +305.84% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $4.13 | +166.34% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.70 | +958.82% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $2.70 | +455.56% | 1 | Jun 28, 2024 | |
| LPTX Leap Therapeutics | Initiates: Buy | $8 | $0.37 | +2,037.32% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.55 | +2,829.87% | 5 | Aug 10, 2023 | |
| ADAP Adaptimmune Therapeutics | Reiterates: Buy | $10 | $0.24 | +4,020.31% | 8 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.12 | +792.86% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $37.76 | +98.62% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $43.00 | -18.60% | 7 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $60 | $2.20 | +2,627.27% | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.49 | +772.48% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $7.35 | +580.27% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.45 | +934.48% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.32 | +7,661.56% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $0.96 | +1,454.89% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.25 | +3,872.98% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $1.53 | +1,011.11% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $2.08 | +7,880.77% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $7.96 | +653.77% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.16 | +4,921.97% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.47 | +1,176.60% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $7.11 | +4,963.29% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $2.79 | -28.19% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $17 | $0.04 | +41,669.04% | 1 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.69 | +306.50% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.16 | +762.07% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.77 | +749.86% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $7.27 | +1,414.11% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.34 | +23,568.64% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $6.16
Upside: +305.84%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $4.13
Upside: +166.34%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.70
Upside: +958.82%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $2.70
Upside: +455.56%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $0.37
Upside: +2,037.32%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.55
Upside: +2,829.87%
Adaptimmune Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $10
Current: $0.24
Upside: +4,020.31%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.12
Upside: +792.86%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $37.76
Upside: +98.62%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $43.00
Upside: -18.60%
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $2.20
Upside: +2,627.27%
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.49
Upside: +772.48%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $7.35
Upside: +580.27%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.45
Upside: +934.48%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.32
Upside: +7,661.56%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $0.96
Upside: +1,454.89%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $0.25
Upside: +3,872.98%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $1.53
Upside: +1,011.11%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $2.08
Upside: +7,880.77%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $7.96
Upside: +653.77%
Jun 5, 2023
Reiterates: Buy
Price Target: $8
Current: $0.16
Upside: +4,921.97%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.47
Upside: +1,176.60%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $7.11
Upside: +4,963.29%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $2.79
Upside: -28.19%
May 25, 2023
Assumes: Buy
Price Target: $17
Current: $0.04
Upside: +41,669.04%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $3.69
Upside: +306.50%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.16
Upside: +762.07%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $1.77
Upside: +749.86%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $7.27
Upside: +1,414.11%
Mar 2, 2020
Initiates: Buy
Price Target: $80
Current: $0.34
Upside: +23,568.64%